Skip to main content
. 2019 Jul 16;7(3):64. doi: 10.3390/vaccines7030064

Table 1.

Study design and nasal immunization of NMRI and C57BL/6 mice against formalin-inactivated Influenza A/H1N1/Salomon Island/2006.

Immunization Schedule
Group n Immunization Days Dose and Immunogen Adjuvant Mouse Strain
1 32 0, 60 1.5 µg HA in whole intact inactivated H1N1 None NMRI
2 32 0, 60 1.5 µg HA in whole intact inactivated H1N1 N3 NMRI
3 16 0, 60 1.5 µg HA in whole intact inactivated H1N1 pFliC(-gly) NMRI
4 32 0, 60 1.5 µg HA in whole intact inactivated H1N1 N3 + pFliC(-gly) NMRI
5 30 0, 60 Saline N3 + pFliC(-gly) NMRI
6 32 0, 56 1.5 µg HA in whole intact inactivated H1N1 None C57BL/6
7 32 0, 56 1.5 µg HA in whole intact inactivated H1N1 N3 C57BL/6
8 12 0, 56 1.5 µg HA in whole intact inactivated H1N1 pFliC(-gly) C57BL/6
9 32 0, 56 1.5 µg HA in whole intact inactivated H1N1 N3 + pFliC(-gly) C57BL/6
10 24 0, 56 Saline N3 + pFliC(-gly) C57BL/6

Abbreviations: HA = Hemagglutinine protein from influenza A, pFliC(-gly) = Plasmid encoding secreted Flagellin type C of Salmonella typhimurium with mammalian glycosylation signal sequences removed.